Literature DB >> 24182774

Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5.

Margarete Focke-Tejkl1, Raffaela Campana2, Renate Reininger3, Christian Lupinek2, Katharina Blatt4, Peter Valent4, Tea Pavkov-Keller5, Walter Keller5, Rudolf Valenta6.   

Abstract

BACKGROUND: The major timothy grass pollen allergen Phl p 5 belongs to the most potent allergens involved in hay fever and asthma.
OBJECTIVE: This study characterized immune-dominant IgE- and T-cell-recognition sites of Phl p 5.
METHODS: Seven peptides, P1 to P7 with a length of 31 to 38 amino acids that spanned the Phl p 5 sequence, were synthesized, characterized by circular dichroism spectroscopy, and tested for IgE reactivity, basophil activation, and T-cell reactivity. Carrier-bound peptides were studied for their ability to induce IgG antibodies in rabbits which recognize Phl p 5 or cross-reactive allergens from different grass species. Peptide-specific antibodies were tested for the capability to inhibit IgE reactivity to Phl p 5 and allergen-induced basophil activation of patients with allergy.
RESULTS: The peptides exhibited no secondary structure and showed no IgE reactivity or relevant allergenic activity, indicating that Phl p 5 IgE epitopes are conformational. Except for P3, peptide-specific IgG antibodies blocked IgE binding to Phl p 5 of patients with allergy and cross-reacted with temperate grasses. IgE inhibition experiments and molecular modeling identified several clustered conformational IgE epitopes on the N- as well as C-terminal domain of Phl p 5. P4, which stimulated the strongest T-cell and cytokine responses in patients, was not part of the major IgE-reactive regions.
CONCLUSION: Our study shows an interesting dissociation of the major IgE- and T-cell-reactive domains in Phl p 5 which provides a basis for the development of novel forms of immunotherapy that selectively target IgE or T-cell responses.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Allergy; epitopes; grass pollen allergen; peptides

Mesh:

Substances:

Year:  2013        PMID: 24182774      PMCID: PMC6624141          DOI: 10.1016/j.jaci.2013.08.038

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  49 in total

1.  Isolation of cDNA encoding a newly identified major allergenic protein of rye-grass pollen: intracellular targeting to the amyloplast.

Authors:  M B Singh; T Hough; P Theerakulpisut; A Avjioglu; S Davies; P M Smith; P Taylor; R J Simpson; L D Ward; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 2.  T cell epitope-based allergy vaccines.

Authors:  Mark Larché
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

3.  Long-term clinical efficacy of grass-pollen immunotherapy.

Authors:  S R Durham; S M Walker; E M Varga; M R Jacobson; F O'Brien; W Noble; S J Till; Q A Hamid; K T Nouri-Aria
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

4.  The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope.

Authors:  Beatrice Jahn-Schmid; Peter Kelemen; Martin Himly; Barbara Bohle; Gottfried Fischer; Fatima Ferreira; Christof Ebner
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

5.  Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen.

Authors:  S M Pollart; M J Reid; J A Fling; M D Chapman; T A Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  1988-08       Impact factor: 10.793

6.  Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination.

Authors:  Mohan B Singh; Prem L Bhalla
Journal:  Immunol Cell Biol       Date:  2003-02       Impact factor: 5.126

7.  High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography.

Authors:  Sivaraman Padavattan; Sabine Flicker; Tilman Schirmer; Christoph Madritsch; Stefanie Randow; Gerald Reese; Stefan Vieths; Christian Lupinek; Christof Ebner; Rudolf Valenta; Zora Markovic-Housley
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.

Authors:  Alexander W Hauswirth; Susanne Natter; Minoo Ghannadan; Yasamin Majlesi; Gerit-Holger Schernthaner; Wolfgang R Sperr; Hans-Jörg Bühring; Rudolf Valenta; Peter Valent
Journal:  J Allergy Clin Immunol       Date:  2002-07       Impact factor: 10.793

9.  A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundle.

Authors:  Ornella Maglio; Jose W Saldanha; Susanne Vrtala; Susanne Spitzauer; Rudolf Valenta; Annalisa Pastore
Journal:  Protein Eng       Date:  2002-08

10.  Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.

Authors:  S Vrtala; S Fischer; M Grote; L Vangelista; A Pastore; W R Sperr; P Valent; R Reichelt; D Kraft; R Valenta
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

View more
  16 in total

1.  Flexible IgE epitope-containing domains of Phl p 5 cause high allergenic activity.

Authors:  Christoph Göbl; Margarete Focke-Tejkl; Nazanin Najafi; Evelyne Schrank; Tobias Madl; Simone Kosol; Christoph Madritsch; Yulia Dorofeeva; Sabine Flicker; Josef Thalhamer; Rudolf Valenta; Klaus Zangger; Nico Tjandra
Journal:  J Allergy Clin Immunol       Date:  2017-05-19       Impact factor: 10.793

Review 2.  Molecular biomarkers for grass pollen immunotherapy.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2014-03-26

3.  Molecular patterns in the isotype-specific antibody responses to the major cedar aeroallergen Jun a 1.

Authors:  Randall M Goldblum; Rumali S Madagoda-Desilva; Yueqing Zhang; Julius van Bavel; Terumi Midoro-Horiuti
Journal:  Mol Immunol       Date:  2018-08-29       Impact factor: 4.407

4.  Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.

Authors:  M Levin; S Rotthus; S Wendel; N Najafi; E Källström; M Focke-Tejkl; R Valenta; S Flicker; M Ohlin
Journal:  Clin Exp Allergy       Date:  2014-11       Impact factor: 5.018

5.  Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy.

Authors:  L D Archila; J H DeLong; E Wambre; E A James; D M Robinson; W W Kwok
Journal:  Clin Exp Allergy       Date:  2014-07       Impact factor: 5.018

6.  Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

Authors:  Margarete Focke-Tejkl; Milena Weber; Katarzyna Niespodziana; Angela Neubauer; Hans Huber; Rainer Henning; Gottfried Stegfellner; Bernhard Maderegger; Martina Hauer; Frank Stolz; Verena Niederberger; Katharina Marth; Julia Eckl-Dorna; Richard Weiss; Josef Thalhamer; Katharina Blatt; Peter Valent; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2014-11-13       Impact factor: 10.793

7.  IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational.

Authors:  Mirela Curin; Huey-Jy Huang; Tetiana Garmatiuk; Sandra Gutfreund; Yvonne Resch-Marat; Kuan-Wei Chen; Kerstin Fauland; Walter Keller; Petra Zieglmayer; René Zieglmayer; Patrick Lemell; Friedrich Horak; Wolfgang Hemmer; Margarete Focke-Tejkl; Sabine Flicker; Susanne Vrtala; Rudolf Valenta
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

8.  Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses.

Authors:  Isabella Radauer-Preiml; Ancuela Andosch; Thomas Hawranek; Ursula Luetz-Meindl; Markus Wiederstein; Jutta Horejs-Hoeck; Martin Himly; Matthew Boyles; Albert Duschl
Journal:  Part Fibre Toxicol       Date:  2016-01-16       Impact factor: 9.400

9.  Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.

Authors:  Petra Zieglmayer; Margarete Focke-Tejkl; René Schmutz; Patrick Lemell; René Zieglmayer; Milena Weber; Renata Kiss; Katharina Blatt; Peter Valent; Frank Stolz; Hans Huber; Angela Neubauer; Anette Knoll; Friedrich Horak; Rainer Henning; Rudolf Valenta
Journal:  EBioMedicine       Date:  2016-08-20       Impact factor: 8.143

10.  Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.

Authors:  Carolin Cornelius; Katrin Schöneweis; Fanny Georgi; Milena Weber; Verena Niederberger; Petra Zieglmayer; Katarzyna Niespodziana; Michael Trauner; Harald Hofer; Stephan Urban; Rudolf Valenta
Journal:  EBioMedicine       Date:  2016-08-08       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.